HIGHLIGHTS
- who: Michela Roberto and colleagues from the Innsbruck Medical University, Austria have published the paper: The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management, in the Journal: (JOURNAL)
- what: For those patients with baseline organ Frontiers in Oncology 2 Patients and method This study reported a case series of mRCC treated at Sapienza University Oncological Units with a special focus on the different toxicities that occurred during IO-based or targeted therapies for mRCC. At the time of first oncological visit, all the patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.